CCO Slideset

Session VIII: New Approaches to Pathway Identification, Predictive/Prognostic Factors, and Biologic Imaging Markers

Source: 6th International Symposium on Translational Research in Oncology

Session VIII: New Approaches to Pathway Identification, Predictive/Prognostic Factors, and Biologic Imaging Markers

Program Directors:

Dennis J. Slamon, MD, PhD
John Crown, MD, MPH

Faculty:

John Crown, MD, MPH

CME CREDIT INFORMATION

Release Date: 01/09/08

Expiration Date: 01/08/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the use of flow cytometry for studying cell signaling mechanisms in cancer
Discuss molecular subtypes in ovarian cancer
Cite epidemiology of ovarian cancer

Topics covered include:

Session VIII: New Approaches to Pathway Identification, Predictive/Prognostic Factors, and Biologic Imaging Markers

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.